Cargando…

STAT3 modulates reprogramming efficiency of human somatic cells; insights from autosomal dominant Hyper IgE syndrome caused by STAT3 mutations

Human induced pluripotent stem cell (iPSC) technology has opened exciting opportunities for stem-cell-based therapy. However, its wide adoption is precluded by several challenges including low reprogramming efficiency and potential for malignant transformation. Better understanding of the molecular...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Zhen, Dmitrieva, Natalia I., Walts, Avram D., Jin, Hui, Liu, Yangtengyu, Ping, Xianfeng, Ferrante, Elisa A., Qiu, Lugui, Holland, Steven M., Freeman, Alexandra F., Chen, Guibin, Boehm, Manfred
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Company of Biologists Ltd 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502598/ https://www.ncbi.nlm.nih.gov/pubmed/32580970 http://dx.doi.org/10.1242/bio.052662

Ejemplares similares

Generation of human induced pluripotent stem cell lines (NIHTVBi011-A, NIHTVBi012-A, NIHTVBi013-A) from autosomal dominant Hyper IgE syndrome (AD-HIES) patients carrying STAT3 mutation
por: Jin, Hui, et al.
Publicado: (2019)

STAT3 Hyper-IgE Syndrome—an Update and Unanswered Questions
por: Tsilifis, Christo, et al.
Publicado: (2021)

Human STAT3 variants underlie autosomal dominant hyper-IgE syndrome by negative dominance
por: Asano, Takaki, et al.
Publicado: (2021)

Spontaneous Gastrointestinal Perforations in STAT3-Deficient Hyper-IgE Syndrome
por: Bhattacharya, Sumona, et al.
Publicado: (2020)

Recurrent Skin and Lung Infections in Autosomal Dominant Hyper IgE Syndrome with Transactivation Domain STAT3 Mutation
por: Cooper, Chad J., et al.
Publicado: (2014)

Eosinophilia and reduced STAT3 signaling affect neutrophil cell death in autosomal‐dominant Hyper‐IgE syndrome
por: Farmand, Susan, et al.
Publicado: (2018)

JAK-STAT3 and somatic cell reprogramming
por: Tang, Yong, et al.
Publicado: (2013)

STAT3-Mediated Transcriptional Regulation of Osteopontin in STAT3 Loss-of-Function Related Hyper IgE Syndrome
por: Goel, Shubham, et al.
Publicado: (2018)

Interventional pulmonary procedures and their outcomes in patients with STAT3 hyper IgE syndrome
por: Mahdaviani, Seyed Alireza, et al.
Publicado: (2023)

Hematopoietic Stem Cell Transplantation and Vasculopathy Associated With STAT3-Dominant-Negative Hyper-IgE Syndrome
por: Ponsford, Mark J., et al.
Publicado: (2020)

Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3
por: Ma, Cindy S., et al.
Publicado: (2008)

Hyper-IgE Syndrome with STAT3 Mutation: A Case Report in Mainland China
por: Xie, Lixin, et al.
Publicado: (2010)

A Novel STAT3 Mutation in a Qatari Patient With Hyper-IgE Syndrome
por: Chaimowitz, Natalia S., et al.
Publicado: (2019)

Molecular Assessment of Staphylococcus Aureus Strains in STAT3 Hyper-IgE Syndrome Patients
por: Schwierzeck, Vera, et al.
Publicado: (2022)

Autosomal-Recessive Hyper-IgE Syndrome
por: Liza, Mohapatra, et al.
Publicado: (2018)

Hyper IgE syndrome associated with novel and recurrent STAT3 mutations: Two case reports
por: Deng, Ying, et al.
Publicado: (2019)

Retained primary teeth in STAT3 hyper-IgE syndrome: early intervention in childhood is essential
por: Meixner, Iris, et al.
Publicado: (2020)

Omalizumab for STAT3 Hyper-IgE Syndromes in Adulthood: A Case Report and Literature Review
por: Lan, Jun, et al.
Publicado: (2022)

A Novel STAT3 Gene Mutation Related Hyper-IgE Syndrome Misdiagnosed as Hidradenitis Suppurativa
por: Shrestha, Pragya, et al.
Publicado: (2018)

Evidence that a STAT3 Mutation Causing Hyper IgE Syndrome Leads to Repression of Transcriptional Activity
por: Bahal, Sameer, et al.
Publicado: (2019)

Clinical Manifestations of Hyper IgE Syndromes
por: Freeman, Alexandra F., et al.
Publicado: (2010)

STAT3 and the Hyper-IgE syndrome: Clinical presentation, genetic origin, pathogenesis, novel findings and remaining uncertainties
por: Mogensen, Trine H.
Publicado: (2013)

Remission of eczema and recovery of Th1 polarization following treatment with Dupilumab in STAT3 hyper IgE syndrome
por: Matucci‐Cerinic, Caterina, et al.
Publicado: (2022)

Disseminated Talaromyces marneffei Infection With STAT3-Hyper-IgE Syndrome: A Case Series and Literature Review
por: Li, Zhengtu, et al.
Publicado: (2023)

An update on the hyper-IgE syndromes
por: Yong, Patrick FK, et al.
Publicado: (2012)

Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome
por: Alonso-Bello, Cesar Daniel, et al.
Publicado: (2019)

Defective Toll-Like Receptors Driven B Cell Response in Hyper IgE Syndrome Patients With STAT3 Mutations
por: Gong, Ruolan, et al.
Publicado: (2021)

Hematopoietic Stem Cell Transplantation Resolves the Immune Deficit Associated with STAT3-Dominant-Negative Hyper-IgE Syndrome
por: Harrison, Stephanie C., et al.
Publicado: (2021)

Erratum to “Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome”
por: Alonso-Bello, Cesar Daniel, et al.
Publicado: (2021)

A Novel STAT3 Mutation in a Patient with Hyper-IgE Syndrome Diagnosed with a Severe Necrotizing Pulmonary Infection
por: Zhao, Ran, et al.
Publicado: (2021)

Intraoral and maxillofacial abnormalities in patients with autosomal dominant hyper-IgE syndrome
por: Tar, Ildikó, et al.
Publicado: (2023)

Molecular Typing of Staphylococcus aureus Isolated from Patients with Autosomal Dominant Hyper IgE Syndrome
por: Sastalla, Inka, et al.
Publicado: (2017)

Stat3 Activation Is Limiting for Reprogramming to Ground State Pluripotency
por: Yang, Jian, et al.
Publicado: (2010)

Extraneous E-Cadherin Engages the Deterministic Process of Somatic Reprogramming through Modulating STAT3 and Erk1/2 Activity
por: Liu, Yu-Hao, et al.
Publicado: (2021)

Progranulin sustains STAT3 hyper‐activation and oncogenic function in colorectal cancer cells
por: Laudisi, Federica, et al.
Publicado: (2019)

Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas
por: Pilati, Camilla, et al.
Publicado: (2011)

Hyper IgE syndrome
por: Dang, Yun, et al.
Publicado: (2014)

Generation of human induced pluripotent stem cells (NIHTVBi004-A, NIHTVBi005-A, NIHTVBi006-A, NIHTVBi007-A, NIHTVBi008-A) from 5 CADASIL patients with NOTCH3 mutation
por: Chen, Guibin, et al.
Publicado: (2020)

STAT3-Mediated Metabolic Reprograming in Cellular Transformation and Implications for Drug Resistance
por: Poli, Valeria, et al.
Publicado: (2015)

Reprogramming Factors Remodel Melanoma Cell Phenotype by Changing Stat3 Expression
por: Wang, Yang, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gmh0jc5u6hcd2h35h6nrgbl6sq